Polyrizon 公司已收到欧洲专利局关于其创新型黏膜黏附鼻腔给药技术的专利发布通知。这一进展标志着该公司在鼻腔药物递送领域的技术创新获得了欧洲专利体系的正式认可,为其相关技术的商业化和知识产权保护奠定了重要基础。
Polyrizon 公司已收到欧洲专利局关于其创新型黏膜黏附鼻腔给药技术的专利发布通知。这一进展标志着该公司在鼻腔药物递送领域的技术创新获得了欧洲专利体系的正式认可,为其相关技术的商业化和知识产权保护奠定了重要基础。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.